Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain (RESTORE)
This study has been completed.
Sponsor:
Biomet, Inc.
Information provided by (Responsible Party):
Biomet, Inc.
ClinicalTrials.gov Identifier:
NCT00819286
First received: January 6, 2009
Last updated: May 1, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this study is to evaluate sternal osteosynthesis, chest wall pain and return to normal activity in open heart surgery patients who had their breast bone closed either with wires or plates.
| Condition | Intervention | Phase |
|---|---|---|
|
Sternal Wound Infection Sternal Non-union Pain Mediastinitis |
Device: SternaLock Rigid Fixation System Device: Wire (control) |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Prospective, Randomized-Controlled, Multicenter Study Evaluating Primary Plating in High-Risk Median Sternotomy Patients for Osteosynthesis and Pain |
Resource links provided by NLM:
Further study details as provided by Biomet, Inc.:
Primary Outcome Measures:
- CT Scan Evaluation of Sternal Bone Healing [ Time Frame: 3 and 6 Months ] [ Designated as safety issue: No ]Quantitative evaluation of sternal bone healing at 5 anatomical locations along the sternum using a 6 point quantitative scale (0= no healing and 5= complete healing)
- Activity Based Total Visual Analog Pain Score [ Time Frame: 6 months ] [ Designated as safety issue: No ]Postoperative VAS pain scores (scale of 0-10 for each; 0= no pain, 10= worst pain imaginable) were evaluated as a function of resting, coughing, sneezing and general movement. The sum of these was used to derive an "Activity Based Total Visual Analog Pain Score", (scale of 0-40; 0= no pain, 40= worst pain imaginable). For this primary endpoint analysis, the total score at 6 months was evaluated.
| Enrollment: | 140 |
| Study Start Date: | November 2008 |
| Study Completion Date: | December 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: wire (control)
patients will have their sternum closed using stainless steel wires.
|
Device: Wire (control)
patients will have their sternum closed using stainless steel wires.
|
|
Experimental: plates
patients will have their sternum closed by rigid fixation using SternaLock plates.
|
Device: SternaLock Rigid Fixation System
patients will have their sternum closed by rigid fixation using SternaLock plates.
|
Detailed Description:
Median sternotomy patients will be randomized to either wire or rigid fixation groups. A scheduled evaluation period will record clinical parameters. Enrollment has ended with one hundred forty (140) patients.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients undergoing median sternotomy;
- Patients eighteen (18) years of age or older;
- Patients presenting two or more risk factors such as diabetes mellitus, Chronic Obstructive Pulmonary Disease, obesity (BMI > 30), osteoporosis, Renal failure, Chronic steroid use, Immunosuppression, Redo sternotomy, Neurologic dysfunction severely affecting ambulation,
- Off mid-line sternotomy
- bilateral IMA use
- Long cardio-pulmonary bypass runs
- Transverse fractures of the sternum
Exclusion Criteria:
- Patients with a non-standard sternotomy;
- Patients with an off-midline sternotomy that reduced the bony margin to <2mm
- Patients under eighteen (18) years of age;
- Patients that are pregnant or currently lactating;
- Patients presenting intra-operative conditions that would require the use of rigid fixation and/or additional post-sternotomy mechanical support beyond wire cerclage due to surgical evaluation,
- Patients defined within the New York Heart Association (NYHA) or Canadian Cardiovascular Society (CCS) functional Class IV for congestive heart failure,
- Patients presenting emergent/salvage cardiac acuity as defined per the Society of Thoracic Surgeons (STS) guidelines: i.e., patients undergoing cardiopulmonary resuscitation en route to the operating room or prior to induction of anesthesia;
- Patients undergoing post-operative revision procedures that treat the original sternotomy in such a way as to affect outcome (antibiotic irrigation, debridement or other treatment to the osteotomy);
- Patients unwilling or unable to return for follow-up;
- Lacking the ability to follow instructions;
- Intraoperative death.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00819286
Locations
| United States, Arizona | |
| St. Joseph's Heart and Lung Institute | |
| Phoenix, Arizona, United States, 85013 | |
| United States, California | |
| University of California Davis Medical Center | |
| Sacramento, California, United States, 95817 | |
| United States, Illinois | |
| University of Chicago | |
| Chicago, Illinois, United States, 60637 | |
| United States, Tennessee | |
| Baptist Memorial Hospital | |
| Memphis, Tennessee, United States, 38120 | |
| United States, Texas | |
| Scott & White Memorial Hospital | |
| Temple, Texas, United States, 76508 | |
| Germany | |
| Leipzig Heart Center | |
| Leipzig, Germany | |
Sponsors and Collaborators
Biomet, Inc.
Investigators
| Study Chair: | Jai Raman, MD | University of Chicago |
| Principal Investigator: | Michael Wong, MD | University of California Davis Medical Center, Sacramento, CA |
| Principal Investigator: | Brian DeGuzmann, MD | St. Joseph's Medical Center, Phoenix, AZ |
| Principal Investigator: | Sven Lehmann, MD | Leipzig Heart Center, Leipzig, Germany |
| Principal Investigator: | Kenton Zehr, MD | Scott & White Memorial Hospital, Temple, TX |
| Principal Investigator: | H Edward Garrett, Jr, MD | Baptist Memorial Hospital, Memphis, TN |
More Information
No publications provided
| Responsible Party: | Biomet, Inc. |
| ClinicalTrials.gov Identifier: | NCT00819286 History of Changes |
| Other Study ID Numbers: | 07071 |
| Study First Received: | January 6, 2009 |
| Results First Received: | December 27, 2011 |
| Last Updated: | May 1, 2013 |
| Health Authority: | United States: Institutional Review Board Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by Biomet, Inc.:
|
open heart surgery |
Additional relevant MeSH terms:
|
Mediastinitis Wound Infection Mediastinal Diseases Thoracic Diseases |
Respiratory Tract Diseases Infection Wounds and Injuries |
ClinicalTrials.gov processed this record on May 21, 2013